Download PDF
Dtsch Med Wochenschr 2018; 143(02): 115-122
DOI: 10.1055/s-0043-124737
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Vorsorge und Screening beim kolorektalen Karzinom[*]

Prevention and Screening in Colorectal Cancer
Axel Eickhoff
,
Dirk Hartmann
,
Ralf Jakobs
,
Dieter Schilling
,
Henning Ernst Adamek
,
Bernd Kohler
,
Claus Benz
,
Joachim Arnold
,
Matthias Harloff
,
Matthias Maier
,
Christian-René de Mas
,
Wolf-Rüdiger Martin
,
Jos Weber
,
Dorothee Dorlars
,
Júlio Carlos Pereira-Lima
Further Information

Publication History

Publication Date:
22 January 2018 (online)

Also available at
    Permissions and Reprints

Prof. Dr. med. Jürgen F. Riemann ist einer der bedeutendsten Visionäre und Vorkämpfer der Prävention des kolorektalen Karzinoms. Das unter seiner Federführung mitentwickelte Vorsorgekonzept, unter anderem mit der Vorsorgekoloskopie ab dem 55. Lebensjahr, gilt anderen europäischen Ländern nach wie vor als Vorbild. Für den vorliegenden Widmungsbeitrag wurde daher bewusst das Thema Darmkrebsvorsorge ausgewählt.

Schlüsselwörter

Kolonkarzinom-Screening - Koloskopie - CT-Kolonografie - fäkaler Hämokkult-Test - Patientenakzeptanz

Key words

colon cancer screening - real colonoscopy - CT colonography - fecal occult blood test - patient acceptance

* Gewidmet Herrn Prof. Dr. med. Jürgen F. Riemann anlässlich seiner Verabschiedung als DMW-Herausgeber.


 

  • Literatur

  • 1 Riemann JF. Ist Evidenz der allein entscheidende Maßstab?. Dtsch Med Wochenschr 2016; 41: 732
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Ferlay J, Soerjomataram I, Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386
    CrossrefPubMedGoogle Scholar
  • 3 Andus T. Klinische Gastroenterologie: Das Buch für Fort- und Weiterbildung plus DVD mit über 1400 Befunden. Stuttgart: Thieme; 2012
    Google Scholar
  • 4 Leitlinienprogramm Onkologie|S3-Leitlinie Kolorektales Karzinom. August 2014. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/021-007OLl_S3_KRK_2014-08-verlaengert.pdf
    PubMedGoogle Scholar
  • 5 Brenner H, Altenhofen L, Katalinic A. et al. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol 2011; 174: 1140-1146
    CrossrefPubMedGoogle Scholar
  • 6 Brenner H, Schrotz-King P, Holleczek B. Rückgang der Inzidenz und Mortalität von Darmkrebs in Deutschland. Dtsch Arztebl Int 2016; 113: 101-106
    PubMedGoogle Scholar
  • 7 Song L, Li Y. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J Gastrointest Oncol 2016; 8: 793-800
    CrossrefPubMedGoogle Scholar
  • 8 van Rossum LGM, van Rijn AF. et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis. Int J Cancer 2011; 128: 1908-1917
    CrossrefPubMedGoogle Scholar
  • 9 Lee JK, Liles EG, Bent S. et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014; 160: 171
    PubMedGoogle Scholar
  • 10 Dhaliwal A, Vlachostergios PJ, Oikonomou KG. et al. Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives. World J Gastrointest Oncol 2015; 7: 178-183
    PubMedGoogle Scholar
  • 11 Zhu MM, Zu XT, Nie F. et al. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. J Dig Dis 2010; 11: 148-160
    PubMedGoogle Scholar
  • 12 Hol L, van Leeram ME, van Ballegooijen M. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.. Gut 2010; 59: 62-68
    CrossrefPubMedGoogle Scholar
  • 13 Ladabaum U, Alvarez-Osorio L, Rösch T. et al. Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. Endoscopy Int Open 2014; 2: E96-E104
    PubMedGoogle Scholar
  • 14 Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.. Ann Intern Med 2009; 150: 162-169
    CrossrefPubMedGoogle Scholar
  • 15 Quintero E, Castells A, Bujanda L. et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.. N Engl J Med 2012; 366: 697-706
    CrossrefPubMedGoogle Scholar
  • 16 Oort FA, van Turenhout ST, Coupé VM. et al. Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.. BMC Cancer 2011; 11: 434 , 2011
    CrossrefPubMedGoogle Scholar
  • 17 Health Quality Ontario. Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses. Ont Health Technol Assess Ser 2009; 9: 1-65
    PubMedGoogle Scholar
  • 18 Denzer U, Beilenhoff U, Eickhoff A. et al. S2k-Leitlinie Qualitätsanforderungen in der gastrointestinalen Endoskopie (Kurzversion), AWMF-Register Nr. 021–022. Erstauflage 2015. Z Gastroenterol 2015; 53: 1496-1530
    PubMedGoogle Scholar
  • 19 Imperiale TF, Ransohoff DF, Itzkowitz SH. et al. Multitarget stool DNA testing for colorectal-cancer screening. New Engl J Med 2014; 370: 1287-1297
    CrossrefPubMedGoogle Scholar
  • 20 Lofton-Day C, Model F, de Vos T. et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008; 54: 414-423
    CrossrefPubMedGoogle Scholar
  • 21 Potter NT, Hurban P, White MN. et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 2014; 60: 1183-1191
    CrossrefPubMedGoogle Scholar
  • 22 de Vos T, Tetzner R, Model F. et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009; 55: 1337-1346
    PubMedGoogle Scholar
  • 23 Wolff WI, Shinya H. Colonofiberoscopy. JAMA 1971; 217: 1509-1512
    CrossrefPubMedGoogle Scholar
  • 24 East JE, Stavrindis M, Thomas-Gibson S. et al. A comparative study of standard vs. high definition colonoscopy for adenoma and hyperplastic polyp detection with optimized withdrawal technique. Aliment Pharmacol Ther 2008; 28: 768-776
    CrossrefPubMedGoogle Scholar
  • 25 Erim T, Rivas JM, Velis E. et al. Role of high definition colonoscopy in colorectal adenomatous polyp detection. World J Gastroenterol 2011; 17: 4001-4006
    CrossrefPubMedGoogle Scholar
  • 26 Testoni PA, Notaristefano C, Vailati C. et al. High-definition colonoscopy with i-Scan: better diagnosis for small polyps and flat adenomas. World J Gastroenterol 2012; 18: 5231-5239
    PubMedGoogle Scholar
  • 27 Schoen RE, Pinsky PF, Weissfeld JL. et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med 2012; 366: 2345-2357
    CrossrefPubMedGoogle Scholar
  • 28 Imperiale TF, Wagner DR, Lin CY. et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. New Engl J Med 2000; 343: 169-174
    CrossrefPubMedGoogle Scholar
  • 29 Holme Ø, Schoen RE, Senore C. et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ (Clinical research ed.) 2017; 356: i6673
    PubMedGoogle Scholar
  • 30 Heresbach D, Djabbari M, Riou F. et al. Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut 2011; 60: 658-665
    CrossrefPubMedGoogle Scholar
  • 31 Johnson CD, Chen M, Toledano AY. et al. Accuracy of CT colonography for detection of large adenomas and cancers. New Engl J Med 2008; 359: 1207-1217
    CrossrefPubMedGoogle Scholar
  • 32 Hartmann D, Bassler B, Schilling D. et al. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 2006; 238: 143-149
    CrossrefPubMedGoogle Scholar
  • 33 Franco DL, Leighton JA, Gurudu SR. Approach to Incomplete Colonoscopy: New Techniques and Technologies. Gastroenterol Hepatol 2017; 13: 476-483
    PubMedGoogle Scholar
  • 34 Schoofs N, Devière J, van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy 2006; 38: 971-977
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Eliakim R, Yassin K, Niv Y. et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy 2009; 41: 1026-1031
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 van Gossum A, Munoz-Navas M, Navas MM. et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. New Engl J Med 2009; 361: 264-270
    CrossrefPubMedGoogle Scholar
  • 37 Riemann JF, Albert J, Altenhofen L. et al. Kolonkapsel als Vorsorge – Untersuchung Positionspapier der Stiftung Lebensblicke. Z Gastroenterol 2016; 54: 259
    Article in Thieme ConnectPubMedGoogle Scholar